Impact of urine flow cytometry parameters on the nuclear matrix protein 22 (NMP22) in the surveillance of urothelial cancer
Main Authors: | R. Sasaki, S.K. Kishino, Y.S. Sato, S.N. Narita |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266616832034091X |
Similar Items
-
Use of urine flow cytometry parameters to improve the diagnostic performance of urine cytology and nuclear matrix protein 22 test for urothelial cancer surveillance
by: R. Sasaki, et al.
Published: (2020-07-01) -
Influencing factors on the NMP-22 urine assay: an experimental model
by: Miyake Makito, et al.
Published: (2012-08-01) -
Detection of Recurrent Bladder Cancer NMP22 Test or Urine Cytology?
by: Saeed Shakeri, et al.
Published: (2012-03-01) -
Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis
by: Liang Q, et al.
Published: (2018-12-01) -
Urine Concentration of Nuclear Matrix Protein 22 for Diagnosis of Transitional Cell Carcinoma of Bladder
by: Mahmoud Djalali, et al.
Published: (2008-12-01)